INFUSYSTEM HOLDINGS, INC Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
INFUSYSTEM HOLDINGS, INC (INFU) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-08-04
- INFUSYSTEM HOLDINGS, INC right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-06-30 was $0.00.
- INFUSYSTEM HOLDINGS, INC right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- INFUSYSTEM HOLDINGS, INC right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-12-31 was $0.00.
- INFUSYSTEM HOLDINGS, INC right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- INFUSYSTEM HOLDINGS, INC right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $37.00K, a 85.20% decline from fiscal 2024.
- INFUSYSTEM HOLDINGS, INC right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $250.00K, a 92.55% decline from fiscal 2023.
- INFUSYSTEM HOLDINGS, INC right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $3.36M, a 18544.44% increase from fiscal 2022.
- INFUSYSTEM HOLDINGS, INC right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $18.00K, a 98.06% decline from fiscal 2021.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month as first filed | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $0.00 10-Q · filed 2026-08-04 | $0.00 derived: sum of 3 quarters · filed 2026-08-04 | $0.00 derived: sum of 4 quarters · filed 2026-08-04 | |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-08 | $0.00 derived: sum of 2 quarters · filed 2026-05-08 | $0.00 derived: sum of 3 quarters · filed 2026-05-08 | $0.00 derived: sum of 4 quarters · filed 2026-08-04 | |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $0.00 derived: sum of 2 quarters · filed 2026-02-27 | $0.00 derived: sum of 3 quarters · filed 2026-08-04 | $37.00K 10-K · filed 2026-02-27 | |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $0.00 derived: sum of 2 quarters · filed 2026-08-04 | $37.00K 10-Q · filed 2025-11-04 | $37.00K derived: sum of 4 quarters · filed 2026-08-04 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $37.00K 10-Q · filed 2026-08-04 | $37.00K derived: sum of 3 quarters · filed 2026-08-04 | $287.00K derived: sum of 4 quarters · filed 2026-08-04 | |
| 2025-03-31 | $37.00K 10-Q · filed 2026-05-08 | $37.00K derived: sum of 2 quarters · filed 2026-05-08 | $287.00K derived: sum of 3 quarters · filed 2026-05-08 | $287.00K derived: sum of 4 quarters · filed 2026-05-08 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $250.00K derived: sum of 2 quarters · filed 2026-02-27 | $250.00K derived: sum of 3 quarters · filed 2026-02-27 | $250.00K 10-K · filed 2026-02-27 | |
| 2024-09-30 | $250.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $250.00K derived: sum of 2 quarters · filed 2025-11-04 | $250.00K 10-Q · filed 2025-11-04 | $3.02M derived: sum of 4 quarters · filed 2025-11-04 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $0.00 10-Q · filed 2025-08-05 | $2.77M derived: sum of 3 quarters · filed 2025-08-05 | $2.95M derived: sum of 4 quarters · filed 2025-08-05 | |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-08 | $2.77M derived: sum of 2 quarters · filed 2025-05-08 | $2.95M derived: sum of 3 quarters · filed 2025-05-08 | $2.98M derived: sum of 4 quarters · filed 2025-05-08 | |
| 2023-12-31 | $2.77M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $2.95M derived: sum of 2 quarters · filed 2025-03-11 | $2.98M derived: sum of 3 quarters · filed 2025-03-11 | $3.36M 10-K · filed 2025-03-11 | |
| 2023-09-30 | $180.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $205.00K derived: sum of 2 quarters · filed 2024-11-08 | $586.00K 10-Q · filed 2024-11-08 | $586.00K derived: sum of 4 quarters · filed 2024-11-08 | |
| 2023-06-30 | $25.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $406.00K 10-Q · filed 2024-08-09 | $406.00K derived: sum of 3 quarters · filed 2024-08-09 | $406.00K derived: sum of 4 quarters · filed 2024-08-09 | |
| 2023-03-31 | $381.00K 10-Q · filed 2024-05-09 | $381.00K derived: sum of 2 quarters · filed 2024-05-09 | $381.00K derived: sum of 3 quarters · filed 2024-05-09 | $399.00K derived: sum of 4 quarters · filed 2024-05-09 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-10 | $0.00 derived: sum of 2 quarters · filed 2024-04-10 | $18.00K derived: sum of 3 quarters · filed 2024-04-10 | $18.00K 10-K · filed 2024-04-10 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $18.00K derived: sum of 2 quarters · filed 2023-11-09 | $18.00K 10-Q · filed 2023-11-09 | $656.00K derived: sum of 4 quarters · filed 2024-04-10 | |
| 2022-06-30 | $18.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $18.00K 10-Q · filed 2023-08-09 | $656.00K derived: sum of 3 quarters · filed 2024-04-10 | $656.00K derived: sum of 4 quarters · filed 2024-04-10 | |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-09 | $638.00K derived: sum of 2 quarters · filed 2024-04-10 | $638.00K derived: sum of 3 quarters · filed 2024-04-10 | $645.00K derived: sum of 4 quarters · filed 2024-04-10 | |
| 2021-12-31 | $638.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-10 | $638.00K derived: sum of 2 quarters · filed 2024-04-10 | $645.00K derived: sum of 3 quarters · filed 2024-04-10 | $926.00K 10-K · filed 2024-04-10 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $7.00K derived: sum of 2 quarters · filed 2022-11-08 | $288.00K 10-Q · filed 2022-11-08 | $292.00K derived: sum of 4 quarters · filed 2023-03-16 | |
| 2021-06-30 | $7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $288.00K 10-Q · filed 2022-08-04 | $292.00K derived: sum of 3 quarters · filed 2023-03-16 | $434.00K derived: sum of 4 quarters · filed 2023-03-16 | |
| 2021-03-31 | $281.00K 10-Q · filed 2022-05-05 | $285.00K derived: sum of 2 quarters · filed 2023-03-16 | $427.00K derived: sum of 3 quarters · filed 2023-03-16 | $427.00K derived: sum of 4 quarters · filed 2023-03-16 | |
| 2020-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $146.00K derived: sum of 2 quarters · filed 2023-03-16 | $146.00K derived: sum of 3 quarters · filed 2023-03-16 | $264.00K 10-K · filed 2023-03-16 | |
| 2020-09-30 | $142.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $142.00K derived: sum of 2 quarters · filed 2021-11-15 | $260.00K 10-Q · filed 2021-11-15 | $1.47M derived: sum of 4 quarters · filed 2022-03-15 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $118.00K 10-Q · filed 2021-08-12 | $1.32M derived: sum of 3 quarters · filed 2022-03-15 | $1.65M derived: sum of 4 quarters · filed 2022-03-15 | |
| 2020-03-31 | $118.00K 10-Q · filed 2021-05-10 | $1.32M derived: sum of 2 quarters · filed 2022-03-15 | $1.65M derived: sum of 3 quarters · filed 2022-03-15 | $4.55M derived: sum of 4 quarters · filed 2022-03-15 | |
| 2019-12-31 | $1.21M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $1.53M derived: sum of 2 quarters · filed 2022-03-15 | $4.43M derived: sum of 3 quarters · filed 2022-03-15 | $4.54M 10-K · filed 2022-03-15 | |
| 2019-09-30 | $323.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $3.23M derived: sum of 2 quarters · filed 2020-11-13 | $3.34M 10-Q · filed 2020-11-13 | ||
| 2019-06-30 | $2.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $3.02M 10-Q · filed 2020-08-14 | |||
| 2019-03-31 | $112.00K 10-Q · filed 2020-05-15 | $3.06M 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |